AGL (Agilon Health) Stock Based Compensation: $39 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AGL Agilon Health Inc AGL
73 GF Score
Price $124.29
GF Value $94.33
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Agilon Health Stock Based Compensation?

Agilon Health AGL +1.37% 73 Stock Based Compensation is $39 Mil as of Mar. 2026. GuruFocus rates AGL with a GF Score™ of 73/100 and a GF Value™ of $94.33 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Agilon Health's Stock Based Compensation for the three months ended in Mar. 2026 was $6 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $39 Mil.

Agilon Health Stock Based Compensation Related Terms

Agilon Health Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Agilon Health's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Agilon Health Stock Based Compensation Chart

Agilon Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial 292.39 28.38 69.50 50.66 49.12

Agilon Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.72 15.38 7.50 9.52 6.26
AGL
73GF Score
Agilon Health Inc AGL
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Agilon Health Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $39 Mil.

What does a Stock Based Compensation of $39 Mil mean?
Agilon Health (AGL) has a Stock Based Compensation of $39 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Agilon Health and its competitors.
Is Agilon Health's Stock Based Compensation too high?
Agilon Health's current Stock Based Compensation is $39 Mil. Overall, Agilon Health has a GF Score™ of 73/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Stock Based Compensation compare to MD and SEM?
Agilon Health's Stock Based Compensation of $39 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Healthcare Providers & Services company?
A good Stock Based Compensation depends on the Healthcare Providers & Services industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Agilon Health and its competitors. Agilon Health's current Stock Based Compensation is $39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Significantly Overvalued. The stock's GF Value™ is $94.33, compared to a current price of $124.29 — trading 31.8% above its estimated fair value. The current Stock Based Compensation is $39 Mil. Agilon Health's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Agilon Health (AGL), the current Stock Based Compensation is $39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilon Health (AGL) Overvalued in 2026?

Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued. The current stock price of $124.29 is trading 31.8% above its estimated GF Value™ of $94.33. GuruFocus considers Agilon Health to be Significantly Overvalued.

Key valuation signals for AGL:

  • Stock Based Compensation: $39 Mil
  • GF Value™: $94.33 vs. price of $124.29 (31.8% above fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Agilon Health Business Description

Address 440 Polaris Parkway, Suite 550, Westerville, OH, USA, 43082
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
73GF Score

Get the complete analysis for AGL

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$124.29
Price
$94.33
GF Value